Collegium Pharmaceutical
COLL
COLL
242 hedge funds and large institutions have $1.1B invested in Collegium Pharmaceutical in 2025 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 77 increasing their positions, 98 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% more capital invested
Capital invested by funds: $1.06B → $1.1B (+$31.5M)
21% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 98
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
242
Holding in Top 10
–
Calls
$617K
Puts
$184K
Top Buyers
| 1 | +$19.9M | |
| 2 | +$14.1M | |
| 3 | +$11.2M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$5.72M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.8M |
Top Sellers
| 1 | -$52.7M | |
| 2 | -$5.02M | |
| 3 | -$4.38M | |
| 4 |
Man Group
London,
United Kingdom
|
-$3.47M |
| 5 |
BlackRock
New York
|
-$3.1M |